Bausch Health Companies Inc.
BHC
Price:
$7.97
Market Cap:
$2.93B
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceut...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1994-03-29
Stock Exchange
NYSE
Ticker
BHC
PE Ratio
[-16.60]
ROE
[-22.86%]
Current Ratio
[1.19]
Dividend Yield
[0%]
Enterprise Value
[23.72B]
Dividend History
The ROE as of November 2024 (TTM) for Bausch Health Companies Inc. (BHC) is -22.86%
According to Bausch Health Companies Inc.’s latest financial reports and current stock price. The company's current ROE is -22.86%. This represents a change of 244.51% compared to the average of -6.64% of the last 4 quarters.
Bausch Health Companies Inc. (BHC) Historical ROE (quarterly & annually)
How has BHC ROE performed in the past?
The mean historical ROE of Bausch Health Companies Inc. over the last ten years is 52.59%. The current -22.86% ROE has changed -143.47% with respect to the historical average. Over the past ten years (40 quarters), BHC's ROE was at its highest in in the March 2021 quarter at 309.64%. The ROE was at its lowest in in the December 2019 quarter at -142.62%.
Average
52.59%
Median
6.35%
Minimum
-167.73%
Maximum
883.96%
Bausch Health Companies Inc. (BHC) ROE by Quarter and Year
Discovering the peaks and valleys of Bausch Health Companies Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.60%
Maximum Annual ROE = 883.96%
Minimum Annual Increase = -946.01%
Minimum Annual ROE = -167.73%
| Year | ROE | Change |
|---|---|---|
| 2023 | 57.93% | 89.08% |
| 2022 | 30.64% | -96.53% |
| 2021 | 883.96% | -946.01% |
| 2020 | -104.49% | -37.71% |
| 2019 | -167.73% | 10.51% |
| 2018 | -151.77% | -469.27% |
| 2017 | 41.10% | -153.78% |
| 2016 | -76.43% | 1.60% |
| 2015 | -4.50% | -126.19% |
| 2014 | 17.20% | -201.63% |
Bausch Health Companies Inc. (BHC) Average ROE
How has BHC ROE performed in the past?
The current ROE of Bausch Health Companies Inc. (BHC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
324.17%
5-year avg
140.06%
10-year avg
52.59%
Bausch Health Companies Inc. (BHC) ROE vs. Peers
How is BHC’s ROE compared to its peers?
Bausch Health Companies Inc.’s ROE is greater than Viatris Inc. (-4.43%), greater than Catalent, Inc. (-11.44%), greater than Mallinckrodt plc (-74.45%), greater than Tilray Brands, Inc. (-6.23%), less than Zoetis Inc. (47.99%), less than PetIQ, Inc. (5.54%), greater than Emergent BioSolutions Inc. (-37.83%), less than Neurocrine Biosciences, Inc. (15.68%), greater than Teva Pharmaceutical Industries Limited (-14.58%), less than Haleon plc (6.54%), less than Takeda Pharmaceutical Company Limited (4.04%), less than Shuttle Pharmaceuticals Holdings, Inc. (0%), greater than Lifecore Biomedical, Inc. (-582.98%), less than Lucy Scientific Discovery Inc. (17.23%), greater than null (-296.96%),
| Company | ROE | Market cap |
|---|---|---|
| -4.43% | $15.96B | |
| -11.44% | $11.07B | |
| -74.45% | $4.52M | |
| -6.23% | $1.21B | |
| 47.99% | $79.84B | |
| 5.54% | $919.17M | |
| -37.83% | $513.67M | |
| 15.68% | $12.72B | |
| -14.58% | $19.40B | |
| 6.54% | $43.68B | |
| 4.04% | $42.42B | |
| 0% | $3.19M | |
| -582.98% | $269.21M | |
| 17.23% | $906.91K | |
| -296.96% | $0 |
Build a custom stock screener for Bausch Health Companies Inc. (BHC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bausch Health Companies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Bausch Health Companies Inc. (BHC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Bausch Health Companies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Bausch Health Companies Inc.'s ROE?
How is the ROE calculated for Bausch Health Companies Inc. (BHC)?
What is the highest ROE for Bausch Health Companies Inc. (BHC)?
What is the 3-year average ROE for Bausch Health Companies Inc. (BHC)?
What is the 5-year average ROE for Bausch Health Companies Inc. (BHC)?
How does the current ROE for Bausch Health Companies Inc. (BHC) compare to its historical average?